Pragma Bio
Latest round
- Series A
Last raised
- Aug 2022
Total raised
- $19M
Investors
- 9
About Pragma Bio
Vast Life Sciences, Inc., also known as Pragma Bioscience, operates from South San Francisco, US. The company engages in discovering and developing small molecules to address various clinical applications, particularly in gastrointestinal and immune-related disorders.16 mn.Vast Life Sciences, Inc. specializes in discovering and developing novel small molecules targeting the gut-immune axis. Utilizing their AI-enabled platform, PIKASO, the company synthesizes Biosynthetic Gene Clusters (BGCs) from gut microbes to produce immune-regulating small molecules.Vast Life Sciences, Inc. generates revenue through strategic partnerships and collaborations with biopharmaceutical organizations, focusing on the commercialization of proprietary small molecules and therapeutic discoveries. Their business model is predominantly B2B, involving licensing arrangements for specific drug candidates.In August 2022, Vast Life Sciences, Inc. The company plans to introduce new products targeting the gut-immune axis and aims for expansion into additional markets across North America and Europe, with specific timelines for launch yet to be disclosed.
Who invested in Pragma Bio
9 investors across 5 rounds
See all investors in Pragma Bio
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Pragma Bio
Who invested in Pragma Bio?
Pragma Bio has 9 investors on record across 5 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Pragma Bio raised?
Pragma Bio has raised 5 venture rounds. Sign up free to see how much each round raised and the total.
When did Pragma Bio last raise money?
Pragma Bio's most recent round on record is a Series A, in Aug 2022.
What does Pragma Bio do?
Pragma Bio is a biotechnology company.
Where is Pragma Bio headquartered?
Pragma Bio is headquartered in South San Francisco, US.
Which VCs invest in companies like Pragma Bio?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Pragma Bio's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Pragma Bio? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.